Joshua E Meyer, MD
Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111-2497
Video: Dr. Joshua Meyer
Hepatobiliary and Pancreatic Cancer Treatment at Fox Chase Cancer Center
(May 29, 2013)
Attending Physician, Radiation Oncology
Assistant Director of the Residency/Fellowship Training Program, Radiation Oncology
Gastrointestinal cancers, including pancreas, liver, esophagus, stomach, instestinal, colon, rectal, and anal cancers. I also treat lung tumors. I specialize in using stereotactic radiation to deliver short courses of radiation with the highest accuracy to well-defined targets while minimizing the risk of side effects.
American Board of Radiology, Radiation Oncology
I joined Fox Chase Cancer Center after completing my residency in radiation oncology at Weill Cornell Medical Center in New York City, having been selected Chief Resident during my final year. During my training, I was fortunate to be able to take care of patients from very diverse backgrounds, and with a variety of illnesses. I was excited to be recruited by Fox Chase to treat gastrointestinal and lung cancer patients.
I particularly enjoy the work I do because of its multidisciplinary nature. Patients with gastrointestinal and lung cancers often get chemotherapy, surgery, and radiation, and I enjoy working with the terrific physicians in other departments to come up with the best possible plan for each patient. I particularly appreciate the opportunity to take the time to explain these decisions to my patients, working to ensure that they understand the reasons behind all of the recommendations that are being made. Cancer diagnosis can be frightening, and it has been my experience that the time I spend to help my patients understand their treatment options is very helpful in easing this apprehension.
My specialties include treating patients with cancer of the pancreas, liver, esophagus, stomach, colon, rectum, and anus, in addition to lung. I also have expertise in using stereotactic radiation, meaning the delivery of short courses of radiation with the highest accuracy, while minimizing the risk of side effects to patients.
In addition to my primary role treating cancer patients, I am also pursuing research into ways that patients can be treated more effectively. My previous research, focused primarily on gastrointestinal cancers, has been presented at numerous national meetings and published in peer-reviewed scientific journals. I have also received the Roentgen Resident/Fellow Research Award from the Radiological Society of North America and was selected as a clinical fellow at the ASCO/AACR Workshop on Methods in Clinical Cancer Research in 2009. It is my goal to use my research to extend and improve the lives of my patients.
MD, University of Massachusetts Medical School, Worcester, MA, 2005
Stich Radiation Center, Weill Cornell Medical Center, New York,
Honors and Awards
Clinical Fellow, ASCO/AACR Workshop on Methods in Clinical Cancer Research, 2009;
Roentgen Resident/Fellow Research Award, 2009;
Lang Research Award, New York Hospital of Queens Residents and Fellows Day, 2009;
American Radium Society Travel Grant, 2009;
2009 ASCO Cancer Foundation Merit Award, 2009;
International Society of Gastrointestinal Oncology Conference Educational Grant, 2008
Research InterestsMy interests are in clinical research for gastrointestinal cancers. This includes the new application of radiation technology to increase surgical resectability and cure rates. It also includes outcomes work to determine which management strategies are the most effective for these patients.
Dr. Meyer on My NCBI
- LS Wang, T Shaikh, EA Handorf, JP Hoffman, SJ Cohen, JE Meyer. Dose Escalation With a Vessel Boost in Borderline Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Chemoradiation. Practical Radiation Oncology 90(1); 2015.
- Shaikh T, Ruth K, Scoot WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE. “Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.” Ann Thorac Surg, 99(1):270-6, 2015
- Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. “HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.” J Gastrointest Cancer, 44(4):450-5; 2013.
- Meyer JE, Cohen SJ. “Beyond First-Line Therapy: Combining Chemotherapy and Radioembolization for Hepatic Colorectal Metastases.” J Nucl Med Radiat Ther 2:1-6; 2011
- Meyer JE, Sherr DL. “Reply to receptive anal intercourse as a potential risk factor for rectal cancer.” Cancer. 117:3284-5; 2011.
- Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. “Increasing incidence of rectal cancer in patients aged younger than 40 years.” Cancer. 116:4354-9; 2010.
- Meyer JE, Sherr DL. “When Less Is More, When Less Is Less: Local Excision in Early Rectal Cancer.” Gastrointest Cancer Res. 3(3): 123-4; 2009.
- Fitzgerald TJ, Simon E, Meyer JE. “Prostate carcinoma: opportunities